A patient with haemorrhagic bullae. Varicella zoster virus (VZV).
Department of Internal Medicine, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands. h.westdorp@jbz.nl
H
H
Westdorp
H A M
HA
Sinnige
D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use; D001768:Blister / Q000175:diagnosis / Q000188:drug therapy; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy; D006562:Herpes Zoster / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014645:Herpesvirus 3, Human; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy; D000069283:Rituximab; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents; D007155:Immunologic Factors; D000069283:Rituximab; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir